Table 6. Analysis of changes in CK2 gene expression in head and neck cancer.
Gene | p-value | Fold Change | Rank (Top %) | Dataset | #Samples | Reference |
---|---|---|---|---|---|---|
Floor of the Mouth Carcinoma | ||||||
CK2α | 1.69 10−4 | 2.313 | 7% | Pyeon Multi-cancer | 84 | [63] |
CK2α’ | 0.011 | 1.99 | 21% | Pyeon Multi-cancer | 84 | [63] |
CK2β | 1.44 10−4 | 1.923 | 6% | Pyeon Multi-cancer | 84 | [63] |
Oral Cavity Squamous Cell Carcinoma | ||||||
CKα | 2.35 10−6 | 1.301 | 11% | Peng Head-Neck | 57 | [76] |
Nasopharyngeal carcinoma | ||||||
CK2α | 5.01 10−5 | 1.381 | 6% | Sengupta Head-Neck | 41 | [77] |
Oropharyngeal Carcinoma | ||||||
CK2α | 6.85 10−4 | 1.737 | 7% | Pyeon Multi-cancer | 84 | [63] |
Tongue Carcinoma | ||||||
CK2α | 1.31 10−6 | 1.735 | 2% | Pyeon Multi-cancer | 84 | [63] |
CK2α’ | 1.74 10−6 | 1.836 | 3% | Pyeon Multi-cancer | 84 | [63] |
CK2β | 5.75 10−4 | 1.689 | 14% | Pyeon Multi-cancer | 84 | [63] |
3.76 10−4 | 1.409 | 19% | Talbot Lung | 93 | [78] | |
0.003 | 1.605 | 23% | Estilo Head-Neck | 58 | [63] | |
Tonsillar Carcinoma | ||||||
CK2β | 0.006 | 1.514 | 7% | Pyeon Multi-cancer | 84 | [63] |